| Name |
Streptomyces clavuligerus Higgens and Kastner 1971 |
|
| Strain designation | ATCC 27064 |
|
| Other collections | CBS 226.75; CCRC 27064; DSM 738; DSM 40751; IFO 13307; IMET 43657; JCM 4710; KCC S-0710; MCRL 0774; NCIMB 12785; NRRL 3585 |
|
| Access in situ (sampling data) |
Source: Soil of South America
Country of access: Unknown
Date of access: Before 24-02-1971 |
|
| History | CECT, 1979 < ATCC < C.E. Higgens, The Lilly Research Laboratories, USA |
|
| Growth conditions | Culture media: 118
Growth temperature (in °C): 30
Incubation time: 72h
Atmospheric needs: aerobic
Cultivation conditions for CECT strains |
|
| Metabolites production | cephalosporin antibiotics 7-(5-amino-5-carboxyvaleramido)-3-carbamoyloxymethyl-3-cephem-4-carboxylic acid, and 7-(5-amino-5-carboxyvaleramido)-3-carbamoyloxymethyl -7-methoxy-3-cephem-4-carboxylic acid |
|
| Enzymes production | 5-(2-aminoadipyl)-cysteinyl-valine synthetase |
|
| Restrictions | Risk group: 1
CECT MTA |
|
| Genetic data | 16S rRNA sequence: AY999718
Complete genome sequence: GCA_000148465.1; GCA_000163875.1; GCA_000154925.1 |
|
| Patents | US patent 4525352, production of clavulanic acid |
|
| Delivery | | Freeze-dried culture | | Acticult® 3R | | Active culture rate A | | Genomic DNA |
Tarifas de presentaciones |
|
|
| La CECT sigue estándares de calidad para garantizar la viabilidad, pureza y autenticidad de las cepas que conserva. La información mostrada en esta ficha procede de diversas fuentes. Algunas de las propiedades no han sido necesariamente contrastadas por la CECT |